Solubilization and characterization of the 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes

Eur J Pharmacol. 1986 Mar 18;122(2):197-204. doi: 10.1016/0014-2999(86)90103-2.

Abstract

The 5-hydroxytryptamine transporter complex from rat cerebral cortical membranes was solubilized with digitonin. The affinity of the solubilized transporter complex for [3H]paroxetine, a very selective and potent inhibitor of 5-hydroxytryptamine uptake, was not affected and remained unchanged when compared with the parent membrane preparation. The solubilization yield of membrane-bound [3H]paroxetine binding sites was 42%. The pharmacological profile of the solubilized transporter complex was similar to that of the intact transporter in membranes of the cerebral cortex, with the exception of tryptamine, which exhibited a 10-fold loss in potency to inhibit [3H]paroxetine binding to the solubilized transporter when compared to membranes. The Stokes radius determined by gel filtration was 7.6 nm. This successful solubilization of the neuronal 5-hydroxytryptamine transporter complex is the starting point for purification of this macromolecular moiety.

MeSH terms

  • Animals
  • Biological Transport
  • Cerebral Cortex / analysis*
  • Cerebral Cortex / metabolism
  • Chromatography, Gel
  • Kinetics
  • Male
  • Membranes / analysis
  • Paroxetine
  • Piperidines / pharmacology
  • Rats
  • Serotonin / analysis*
  • Serotonin / metabolism

Substances

  • Piperidines
  • Serotonin
  • Paroxetine